Podcasts about Tandem

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Many people fantasize about exploring intimacy with three people, but very few know how to talk about it or where to begin. In this episode, I walk through communication steps, boundary-setting, and five setups that help people feel grounded instead of overwhelmed.In this episode, I break down what people over 50 are most curious about when it comes to trying a threesome. You get clear guidance on communication, consent, emotional grounding, and five practical positions that make a threesome feel exciting instead of overwhelming. This episode gives you structure, safety, and real world tips you can use to talk with your partner before anything happens.Timestamps:In this episode: 00:00 Intro. Why group intimacy is a top fantasy00:20 What makes a three person experience different00:45 Welcome to Taboo to Truth01:05 The reality of trying a threesome in midlife01:32 The question no one asks. What do you do with three bodies01:55 Five setups to make things feel comfortable02:05 The disclaimer on dynamics02:18 Why talking before touching matters02:52 Boundaries, desires, and clear agreements03:18 Position 1. Lounge chair03:45 Position 2. Tandem touch04:15 Position 3. Side by side connection04:42 Position 4. Double rider05:15 Position 5. The bridge05:55 Essentials. Consent, protection, and sharing the spotlight06:25 Laughing off the awkward parts06:48 Final thoughts on curiosity and exploration07:00 Closing Want a deeper look? Watch the full episode on YouTube for a more visual experience of today's discussion. This episode is best enjoyed on video—don't miss out!Karen Bigman, a Sexual Health Alliance Certified Sex Educator, Life, and Menopause Coach, tackles the often-taboo subject of sexuality with a straightforward and candid approach. We explore the intricacies of sex during perimenopause, post-menopause, and andropause, offering insights and support for all those experiencing these transformative phases.This podcast is not intended to give medical advice. Karen Bigman is not a medical professional. For any medical questions or issues, please visit your licensed medical provider.Looking for some fresh perspective on sex in midlife? You can find me here:Email: karen@taboototruth.comWebsite: https://www.taboototruth.com/Instagram: https://www.instagram.com/taboototruthYouTube: https://www.youtube.com/@taboototruthpodcastKaren Bigman, a Sexual Health Alliance Certified Sex Educator, Life, and Menopause Coach, tackles the often-taboo subject of sexuality with a straightforward and candid approach. We explore the intricacies of sex during perimenopause, post-menopause, and andropause, offering insights and support for all those experiencing these transformative phases.This podcast is not intended to give medical advice. Karen Bigman is not a medical professional. For any medical questions or issues, please visit your licensed medical provider.Looking for some fresh perspective on sex in midlife? You can find me here:Email: karen@taboototruth.comWebsite:

Fahrradrahmen können schnell sein — wenn sie aerodynamisch geformt sind. Wie geht das und was macht das aus? (00:00:41) Begrüßung (00:03:48) Lufti mit Jens Klötzer (00:05:40) Verhältnis Rahmen zu Sitzposition und Kleidung (00:07:36) Warum weniger Tropfenformen? (00:10:17) Der Trend Aero-Rad (00:13:54) Was ist ein NACA Profil (00:15:27) Was ist entscheidend am Rahmen für die Aerodynamik? (00:20:45) Spannungsfeld Komfort – Aerodynamik (00:24:25) Welchen Effekt hat ein rundes Rohr? (00:27:32) Kleine Details – sind die wichtig? (00:35:24) Lenkerform (00:39:43) Einfachantriebe (00:41:10) Spezialfrage – Tasche vor dem Lenker (00:46:36) Ausblick und Verabschiedung (00:50:36) Musik: Trettmann x Jassin – Nach Hause komm Hier geht's zum Gespräch über Felix' Traumrad aus Titan: https://detektor.fm/gesellschaft/antritt-rad-meiner-traeume-felix-traeumt-von-titan Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-aerodynamik-am-fahrradrahmen

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Fahrradrahmen können schnell sein — wenn sie aerodynamisch geformt sind. Wie geht das und was macht das aus? (00:00:41) Begrüßung (00:03:48) Lufti mit Jens Klötzer (00:05:40) Verhältnis Rahmen zu Sitzposition und Kleidung (00:07:36) Warum weniger Tropfenformen? (00:10:17) Der Trend Aero-Rad (00:13:54) Was ist ein NACA Profil (00:15:27) Was ist entscheidend am Rahmen für die Aerodynamik? (00:20:45) Spannungsfeld Komfort – Aerodynamik (00:24:25) Welchen Effekt hat ein rundes Rohr? (00:27:32) Kleine Details – sind die wichtig? (00:35:24) Lenkerform (00:39:43) Einfachantriebe (00:41:10) Spezialfrage – Tasche vor dem Lenker (00:46:36) Ausblick und Verabschiedung (00:50:36) Musik: Trettmann x Jassin – Nach Hause komm Hier geht's zum Gespräch über Felix' Traumrad aus Titan: https://detektor.fm/gesellschaft/antritt-rad-meiner-traeume-felix-traeumt-von-titan Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-aerodynamik-am-fahrradrahmen

Fahrradrahmen können schnell sein — wenn sie aerodynamisch geformt sind. Wie geht das und was macht das aus? (00:00:41) Begrüßung (00:03:48) Lufti mit Jens Klötzer (00:05:40) Verhältnis Rahmen zu Sitzposition und Kleidung (00:07:36) Warum weniger Tropfenformen? (00:10:17) Der Trend Aero-Rad (00:13:54) Was ist ein NACA Profil (00:15:27) Was ist entscheidend am Rahmen für die Aerodynamik? (00:20:45) Spannungsfeld Komfort – Aerodynamik (00:24:25) Welchen Effekt hat ein rundes Rohr? (00:27:32) Kleine Details – sind die wichtig? (00:35:24) Lenkerform (00:39:43) Einfachantriebe (00:41:10) Spezialfrage – Tasche vor dem Lenker (00:46:36) Ausblick und Verabschiedung (00:50:36) Musik: Trettmann x Jassin – Nach Hause komm Hier geht's zum Gespräch über Felix' Traumrad aus Titan: https://detektor.fm/gesellschaft/antritt-rad-meiner-traeume-felix-traeumt-von-titan Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-aerodynamik-am-fahrradrahmen

Welcome back to the Tandem Talk Show with Coach G — in this inspiring episode we welcome returning guest Elaine (previously featured on episode 138) to share the next chapter of her transformation. Elaine candidly walks through the major obstacles she faced before joining Tandem, including surgical menopause, a Hashimoto's thyroid diagnosis, vitamin deficiencies, and a severe car accident that left her in a wheelchair for 10 weeks. Despite these hurdles, she describes how she lost over 50 pounds through Tandem's coaching and structured programming. Coach G and Elaine discuss the phases of the program she completed — fat loss phases and the Metabolic Reset Phase (MRP) — and how MRP helped reignite her metabolism, increase calories strategically, build muscle, reduce hunger, and make the weight sustainable. Elaine credits Coach Gus for rebuilding her confidence and making exercise enjoyable, and she describes how movement, strength training, and better nutrition reshaped her body and life. The conversation covers practical changes that produced results: simple, trackable daily goals (calories, protein, water, steps), accessible workouts (starting from home and progressing to the gym), meal strategies and prep, and the mental shift from “living to eat” to “eating to live.” Elaine also reflects on the unexpected social and emotional benefits — new friendships, increased energy, improved cardiovascular fitness, and even signing up for a 10K. This episode offers encouragement and clear takeaways for listeners, especially women navigating menopause or thyroid issues who feel weight loss is impossible. Elaine emphasizes readiness, self-investment, following a coach, and small consistent steps. Coach G closes by inviting listeners to reach out to learn more about Tandem's Metabolic Reset Program; you can contact Garrett at garrett@tandemnutrition.com for a free call to discuss goals and whether the program could be a fit.

‘Think about the 20% of things that make 80% of the difference.'Last week I spoke about my own experience of using a tubed vs tubeless automated insulin delivery system to manage my type 1 diabetes. But for a full breakdown of the current hybrid closed loop systems on the market, I knew I had to call in some expert help.John Pemberton's wisdom and knowledge was made abundantly clear in his recent episode of Type 1 on 1. The diabetes specialist dietician, diabetes technology consultant, diabetes educator, type 1 diabetic and founder of The Glucose Never Lies spoke candidly to me about why he dedicates so much of his time to building an online resource to help people living with type 1 diabetes.This episode is a special focus on the four main automated insulin delivery (AID) insulin pump systems currently on the market, using John's helpful superhero personas to take a deep dive into each one, and highlight the most important features among this almighty line up.Spoiler: They're all great, and there is no wrong choice.But if you're curious about insulin pumps and haven't yet been able to find a way to compare them all, this one's for you. The automated insulin delivery systems we dig into in this episode are:Tandem Control IQ: Control and flexibility aka Spider-ManCamAPS FX mylife Loop: Highly adaptable and strategic aka BatmanOmnipod 5: Sleek, simple, and futuristic aka Iron ManMedtronic 780G: Powerful and aggressive aka The HulkDISCLAIMER Nothing you hear on Type 1 on 1 should be taken as medical advice. Please consult your healthcare team before making any changes to your diabetes or health management.CONNECT WITH JOHNJohn's first episode on Type 1 on 1 (Spotify)John's first episode on Type 1 on 1 (YouTube)More information on CGM RegulationThe Glucose Never Lies: Choosing your AID superheroThe Glucose Never Lies WebsiteThe Glucose Never Lies Podcast on SpotifyJOIN THE TYPE 1 ON 1 COMMUNITY: Come and say hi @studiotype1on1 on Instagram.Visit the Type 1 on 1 website.Subscribe to the Type 1 on 1 newsletter.SPONSOR MESSAGEThis episode of Type 1 on 1 is sponsored by Dexcom. Using Dexcom CGM has given me so much confidence to make informed diabetes treatment decisions in the moment.You can choose to wear it on your arm or your abdomen, and all Dexcom CGMs have the share and follow feature even when connected to an insulin pump, so family and friends can see your glucose levels and get alerts, giving that extra bit of support when needed.Head to Dexcom.com to request a free Dexcom ONE+ sample.Always read the user manual for important product aspects and limitations. Talk to your doctor for diabetes management terms and conditions and terms of use. 

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Spine specialist, Dr. Nate McKee shares a success story about a patient with tandem stenosis. Dr. Nate McKee grew up in Fort Wayne, IN. He was first introduced to the great state of Michigan, when he attended Albion College. At Albion College, Dr. Nate received his Bachelor's in Exercise Sciences. He then went onto National University of Health Sciences in Lombard, IL where he received his Doctorate in Chiropractic. While at National, he was actively involved in the Student American Chiropractic Association, and was President. During that involvement he lobbied in Washington, D.C. for rights and access for chiropractic patients such as: Veteran's access, underserved areas, Tricare, etc. Dr. Nate was also a school tutor for Head & Neck and Thoracic Evaluation, Management, and Manipulation courses for two years. During his clinical experience, Dr. Nate did a 2 month rotation at the Roudebush VA Medical Center in Indianapolis, IN.  Dr. Nate has furthered his education and received a certification in Cox Decompression and Manipulation Technic. His education in Cox Technic allows him to treat various conditions of the neck, back, and knees such as but not limited to: disc herniations, spinal stenosis, post surgical pain, back pain related to pregnancy, headaches, and meniscal pain of the knee.  Dr. Nate is also a Certified Chiropractic Sports Physician® (CCSP®), which has equipped him with the training to treat and prevent sports injuries and to properly work with athletes.  References: Chiropractic Management using Cox Technic Flexion Distraction for a Patient With Tandem Spinal Stenosis Resources: Connect with Dr. McKee Dr. Mckee's office 810-223-2439 Connect on Facebook Instagram @McKeeChiro Find a Back Doctor The Cox 8 Table by Haven Medical

What happens when partnership doesn't just work in private life, but also becomes a strong leadership duo at work? In this Team Behind the Scenes episode of the LEITWOLF® Podcast, Stefan speaks with his wife and business partner, Tanja Homeister, about how their relationship has evolved into an effective leadership partnership. Tanja is the “Heart of Operations” behind the scenes – bringing structure, communication, and reliability to the work that enables impact. Stefan brings vision, energy and ideas; Tanja ensures they land and create results. Together, they talk about how they clarify roles, navigate conflict without drama, set boundaries between work and private life, and make invisible work visible and valued. A personal and honest conversation about how two different perspectives can create stronger leadership together. ––– Do you like the LEITWOLF® Leadership podcast? Then please rate it with a star rating and review it on iTunes or/and Spotify. This will help us to further improve this LEITWOLF® podcast and make it more visible. ––– Book your access to the LEITWOLF® Academy NOW: https://stefan-homeister-leadership.com/link/leitwolf-academy-en Would you like solid tips or support on how to implement good leadership in your company? Then please get in touch with Stefan via mail: homeister@stefan-homeister-leadership.com Or arrange a free phone call here: https://stefan-homeister-leadership.com/link/calendly-en // LINKEDIN: https://stefan-homeister-leadership.com/link/linkedin // WEBSITE: https://stefan-homeister-leadership.com ® 2017 STEFAN HOMEISTER LEITWOLF® ALL RIGHTS RESERVE ___ LEITWOLF Podcast, Leadership, Management, Stefan Homeister, Podcast, Business Leadership, Successful Leadership, Organizational Management, Leadership Skills, Leadership Development, Team Management, Self-leadership, Leadership Coaching, Leadership Training, Career Development, Leadership Personality, Success Strategies, Organizational Culture, Motivation and Leadership, Leadership Tips, Leadership Insights, Change Management, Visionary Leadership, Leadership Interviews, Successful Managers, Entrepreneurial Tips, Leadership Best Practices, Leadership Perspectives, Business Coaching

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. Our top story this week: XX Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least seven people and more than 700 serious injuries worldwide, according to an alert from the US Food and Drug Administration.   Incorrect glucose readings can lead to improper treatment. Abbott warned that about 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected, but no other Libre products. Patients can visit FreeStyleCheck.com to see if their sensors are affected and to get a replacement for free.   The FDA has also published specific information about the affected products in its alert. The agency considers this to be a "potentially high-risk issue" and will continue to update its website as information becomes available.   "Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor(s)," the FDA said.   https://www.cnn.com/2025/12/02/health/abbott-diabetes-glucose-monitors https://www.freestylecheck.com/us-en/home.html XX Omnipod 5 is getting some enhancements.. and Omnipod 6 is announced. The FDA cleared updates including  a lower, 100 mg/dL target glucose option and what they call a more seamless automated experience. "This is the most significant algorithm advancement to our Omnipod 5 System since its launch in 2022," said Eric Benjamin, Insulet EVP and COO. Insulet said the new 100 mg/dL target glucose expands Omnipod 5's customization range. It now features six settings between 100 mg/dL and 150 mg/dL in 10 mg/dL increments. The company said this flexibility allows healthcare providers to tailor insulin delivery more precisely. It supports individuals seeking tighter glucose management or aiming to meet specific glucose goals. Omnipod 5's latest upgrades also help users stay in "Automated Mode" with fewer interruptions, even during prolonged high glucose events. Insulet plans to launch the updates to the algorithm in the first half of 2026. The company announced plans for an Omnipod 6 – without a lot of detail - at the company's Investor Day event in November. They also talked about a new, fully closed-loop pump for the type 2 diabetes population. https://www.drugdeliverybusiness.com/insulet-fda-clearance-omnipod-5-algorithm-enhancements/ XX Dexcom, the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System will launch in the United States on Dec. 1, making it the longest-lasting CGM system with 15.5 days of wear.   Dexcom G7 15 Day will first be available through durable medical equipment (DME) providers on Dec. 1 with full retail launch in the coming weeks. Dexcom G7 15 Day will also be covered for Medicare beneficiaries.   Dexcom G7 15 Day's industry-leading wear-time will provide fewer sensor changes, less disruption and more time for people with diabetes to benefit from life-changing CGM technology.   New with Dexcom G7 15 Day:  Longest lasting CGM system with 15.5 days of wear. Best-in-class accuracy1 with an overall MARD of 8.0%. Easier glucose management with fewer monthly sensor changes and reduced monthly waste. This follows yesterday's announcement – the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults 18 and older with Type 2 diabetes using long-acting insulin. Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as directed by their healthcare provider. At launch, Dexcom G7 15 Day will connect with the iLet Bionic Pancreas and Omnipod® 5§§. We are working closely with Tandem and look forward to extending the launch to their customers shortly as they finalize integration. For specific information on pump compatibility and availability with the Dexcom G7 15 Day system, visit Dexcom.com/connectedpumps https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Continuous-Glucose-Monitoring-System-to-Launch-on-Dec--1-in-the-United-States/default.aspx   XX A small study of ten adults with type 1 diabetes tested Tandem's new fully closed-loop "Freedom" insulin system — and the participants put it through a real-world stress test. For 72 hours in a hotel setting, they ate heavy carb-and-fat meals, skipped all meal announcements, and didn't give any mealtime insulin boluses. The system handled almost everything automatically. Researchers said the device stayed in closed-loop mode 97% of the time and there were no incidents of diabetic ketoacidosis or severe hypoglycemia reported. While using the Freedom system, participants spent a median 61% of the day in the glucose target range — slightly higher than the 56% achieved with their usual pump at home. But the biggest improvement came overnight: time in range jumped to 96% with the closed-loop system compared to just under 70% during their home-pump week. With almost zero time spent below 70 mg/dL, researchers concluded that the fully automated Tandem system was both safe and effective even with unannounced, high-impact meals — hinting at a future of diabetes management that demands less effort from users.   XX Novo Nordisk reported promising mid-stage results for its experimental drug amycretin (AM-ee-creht-in) in diabetes patients on Tuesday. Amycretin, targets both GLP-1 and amylin hormones. In this study, it helped patients with type 2 diabetes lose up to 14.5% of their body weight over 36 weeks with weekly injections, far outperforming a placebo. The oral version delivered weight loss of up to 10.1%. Rival Eli Lilly  is surging ahead with its own amylin-based drug, eloralintide, which is advancing to late-stage testing after helping patients shed as much as 20% of their weight in a mid-stage trial. https://www.cnbc.com/2025/11/25/novos-next-gen-obesity-drug-shows-positive-results-heads-to-late-stage-testing.html XX The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs. The prices go into effect in 2027, including a monthly price of $274 for Novo Nordisk's popular GLP-1 drug semaglutide, sold as Wegovy for weight loss and Ozempic for diabetes. medicare's recent net price for Ozempic, opens new tab was $428 a month, according to an analysis published in the Journal of Managed Care and Specialty Pharmacy. Medicare put the drug's list price, before confidential rebates and discounts, at $959 a month. Based on such nondiscounted list prices, Medicare said savings on the 15 drugs ranged from 38% to 85%. The annual price negotiations were established under President Joe Biden's signature Inflation Reduction Act (IRA) of 2022. Previously, Medicare was barred by law from negotiating with drugmakers. https://www.reuters.com/business/healthcare-pharmaceuticals/us-negotiated-medicare-prices-15-more-drugs-test-cost-savings-promise-2025-11-25/   XX LifeScan announced its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval. LifeScan said it's positioned to emerge from its financial restructuring process by the end of the year. The CEO says, "This balance sheet restructuring provides a stronger foundation for LifeScan to support our base business, advance new growth strategies, and commence our journey to become one of the most comprehensive players in the glucose management space." https://www.drugdeliverybusiness.com/glucose-monitor-lifescan-emerge-from-bankruptcy/ XX An artificial intelligence (AI)-led Diabetes Prevention Program (DPP) was as effective as a traditional human-led program in achieving recommended goals for weight loss, A1c reduction, and physical activity, according to a randomized trial of adults with prediabetes and overweight or obesity. One example of a push notification: "Looks like you're at the grocery store, Rita! Want a quick list of high-fiber snacks or smart swaps to stay on track this week?" The app also provided location- and goal-based education, with gamification elements to promote engagement. Approximately one third of participants in both the AI and human-led groups achieved the primary outcome (31.7% and 31.9%, respectively). Results were consistent across sensitivity analyses and individual components of the composite endpoint. "As more AI-based programs emerge, head-to-head comparisons among different AI-DPPs will be informative. An AI-led approach will not suit everyone; some individuals benefit more from human interaction and accountability," said Mathioudakis, adding that future research should focus on best matching patients to the modalities they prefer. https://www.medscape.com/viewarticle/ai-directed-diabetes-prevention-program-effective-human-2025a1000xam XX A new study suggets metformin could help people with type 1, reducing the need for insulin.  The researchers were surprised to find that metformin did not improve insulin resistance or change blood sugar levels. This suggests that, unlike in type 2 diabetes, metformin doesn't combat insulin resistance in type 1 diabetes.   However, metformin did reduce the amount of insulin people needed to keep their blood sugar levels stable.   https://www.the-express.com/news/health/192157/diabetes-medicine-insulin-type-1 XX Beyond Type 1 launches #TheBeyondType campaign in India to combat type 1 diabetes stigma. Nick Jonas is one of the founders of Beyond Type 1, his wife, Priyanka Chopra Jonas is his partner in this new non profit. The initiative highlights inspiring individuals living with T1D and partners with local organisations to improve awareness, medical support, and community networks for affected families across the nation. India has more young people living with T1D than any other nation, yet understanding of the condition remains limited. Beyond Type 1 is partnering with grassroots organisations across high-need regions. These include HRIDAY in Delhi–NCR, Nityaasha Foundation in Pune, Gram Jyoti in Jharkhand, and SAMATVAM Trust in Bangalore—each group focusing on improving awareness, providing medical support and building stronger community networks for young people with T1D.

In this comprehensive episode of the HVAC School podcast, host Bryan Orr sits down with three experts from Copeland to demystify tandem and trio compressor systems. Joining him are Gina Kahle (Multiples Engineering Manager with 12+ years at Copeland), Tyler Daniels (Product Management team member), and James Stevenson (Technical Sales veteran with 28 years of field experience). Together, they provide both the engineering perspective and real-world service insights that technicians need to understand these increasingly common systems. The conversation begins with the fundamentals: tandem and trio systems represent an evolution in compression modulation, allowing multiple compressors to work together on a single circuit rather than requiring separate circuits for each compressor. This design philosophy delivers significant advantages, including energy savings through better modulation, simplified system design, reduced costs, and the ability to meet stringent minimum modulation requirements (such as the 25% threshold for units under 60,000 BTUs per hour). The team emphasizes that tandems aren't just about pairing any two compressors together—Copeland engineers carefully consider application requirements, flow characteristics, and stress testing to ensure reliable oil management and system resonance control. A major focus of the discussion centers on practical service considerations that every technician needs to understand. James provides invaluable guidance on identifying whether a failed compressor in a tandem system can be replaced individually or requires replacing the entire tandem assembly. The "rule of thumb" is clear: compressors small enough to fit in residential systems (typically under 10 horsepower or about 7 inches in diameter) generally require full tandem replacement, while larger units may allow single compressor replacement. The distinction between "tandem ready" and non-tandem ready compressors becomes critical here—larger compressors (10+ horsepower) are typically sold tandem ready at wholesalers with the necessary oil equalization ports and sight glass connections, while smaller units are not. The episode also explores advanced topics, including the integration of Enhanced Vapor Injection (EVI) technology with tandem systems, particularly for cold climate heat pump applications. Gina explains how EVI extends the operating envelope down to -40°F, opening new markets and applications. The team discusses the transition to A2L refrigerants and how Copeland continues to innovate despite changing regulatory landscapes. Throughout the conversation, they emphasize the critical importance of proper oil management through oil equalization lines (OEL) and two-phase transfer lines (TPTL), and why maintaining these connections exactly as designed is non-negotiable for system longevity. Key Topics Covered: Tandem and Trio Basics: Definition and benefits, including energy savings, cost reduction, and design simplification Modulation Requirements: Meeting state-mandated minimum modulation thresholds (25% for units under 60,000 BTU/hr) Applications: Data centers, DOAS units, rooftops, chillers, and various commercial spaces Compressor Pairing Options: Fixed speed, digital, variable speed, two-stage, and mixed configurations Oil Management: Critical importance of oil equalization lines (OEL), two-phase transfer lines (TPTL), and gas equalization lines (GEL) Service and Replacement: How to identify tandem-ready vs. non-tandem-ready compressors; when to replace individual compressors vs. full tandem assemblies Visual Identification: Using compressor size (7" vs 9" diameter), port configuration, and horsepower ratings to determine replacement strategy Piping Configurations: Three-pipe vs. four-pipe designs and when each is necessary Installation Considerations: Importance of keeping oil equalization lines level (parallel to ground) and using proper mounting spacers Enhanced Vapor Injection (EVI): How EVI technology extends operating envelopes to -40°F for cold climate heat pump applications Energy Efficiency Standards: Meeting IEER, IPLV, and upcoming IVEC standards through strategic tandem use Copeland Mobile App: Features, including parts lookup, resistance specifications, amperage mapping, AI Scout assistant, and technical bulletins   Learn about the Copeland Mobile app at https://www.copeland.com/en-us/tools-resources/mobile-apps/copeland-mobile.  Have a question that you want us to answer on the podcast? Submit your questions at https://www.speakpipe.com/hvacschool. Purchase your tickets or learn more about the 7th Annual HVACR Training Symposium at https://hvacrschool.com/symposium. Subscribe to our podcast on your iPhone or Android. Subscribe to our YouTube channel. Check out our handy calculators here or on the HVAC School Mobile App for Apple and Android.

Was passiert, wenn Partnerschaft nicht nur privat, sondern auch beruflich trägt? In dieser Team-Behind-the-Scenes-Folge des LEITWOLF® Podcasts spricht Stefan mit seiner Frau und Business-Partnerin Tanja Homeister darüber, wie aus ihrer Beziehung ein starkes Leadership-Tandem geworden ist. Tanja ist im Hintergrund das „Heart of Operations“ – verantwortlich für Office, Kommunikation, Struktur und reibungslose Abläufe. Stefan bringt Vision, Energie und neue Ideen, Tanja sorgt dafür, dass sie ankommen und wirken. Gemeinsam sprechen die beiden darüber, wie sie Rollen klären, Konflikte ohne Drama lösen, Grenzen zwischen Arbeit und Privatleben ziehen und wie unsichtbare Arbeit sichtbar und wertgeschätzt wird. Eine persönliche und ehrliche Folge darüber, wie zwei unterschiedliche Perspektiven gemeinsam mehr Führungskraft entfalten können. ––– Nimm gerne an dieser anonymen Umfrage teil, damit wir diesen Podcast für Dich optimieren können: https://forms.gle/WTqCeutVXV2PsjBH9 Gefällt Dir dieser LEITWOLF® Leadership Podcast? Dann abonniere den Podcast und beurteile ihn bitte mit einer Sternebewertung und Rezension bei iTunes und/oder Spotify. Das hilft uns, diesen LEITWOLF® Podcast weiter zu verbessern und sichtbarer zu machen. ––– Buche Dir JETZT Deinen Zugang zur LEITWOLF® Academy: https://stefan-homeister-leadership.com/link/leitwolf-academy Möchtest Du konkrete Tipps oder Unterstützung, wie gutes Führen in Deinem Unternehmen definiert und umgesetzt werden kann, dann schreibe Stefan eine Mail an: homeister@stefan-homeister-leadership.com ODER Vereinbare hier direkt ein kostenloses Beratungsgespräch mit Stefan: https://stefan-homeister-leadership.com/link/calendly // LINKEDIN: https://stefan-homeister-leadership.com/link/linkedin // WEBSITE: https://stefan-homeister-leadership.com ® 2017 STEFAN HOMEISTER LEITWOLF® ALL RIGHTS RESERVED ____ LEITWOLF Podcast, Leadership, Führung, Management, Stefan Homeister, Podcast, Business Leadership, Erfolgreich führen, Unternehmensführung, Führungskompetenz, Leadership Development, Teammanagement, Leadership Skills, Selbstführung, Leadership Coaching, Leadership Training, Karriereentwicklung, Führungspersönlichkeit, Erfolgsstrategien, Unternehmenskultur, Motivation und Leadership, Leadership-Tipps, Leadership Insights, Change Management, Visionäre Führung, Leadership Interviews, Erfolgreiche Manager, Unternehmer-Tipps, Leadership-Best Practices, Leadership-Perspektiven, Business-Coaching

Tad Toad likes playing in the rain. Tad Toad doesn't. Can they still be best friends?

Don't sacrifice your marriage for your business! Robert and Kaylee Fukui, the Married Entrepreneurs, share their powerful story—from the brink of burnout and personal tragedy to creating a thriving life and business in Tandem. Learn their simple, game-changing strategies, including setting boundaries, maximizing time, and the surprisingly hard step of praying together daily. This episode is a must-listen for founders, pastors, and anyone married to an entrepreneur.Grab Robert and Kaylee's free download, "Five Daily Habits to Thrive in Tandem," and check out their book, Tandem, at marriedentrepreneur.co/bam!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Eurobike-Chef Stefan Reisinger spricht über die Zukunft der Messe. Außerdem geht es um Bekleidung fürs Radfahren bei Nässe und Kälte. (00:00:00) Intro (00:00:44) Begrüßung und Bahngeschichten (00:07:18) Themenübersicht (00:08:06) Eurobike-Chef Stefan Reisinger im Gespräch (00:11:41) Kritikpunkte und Anforderungen an die Messe (00:17:16) mobifuture und regulatorische Herausforderungen (00:22:06) Sicht auf Cyclingworld Düsseldorf (00:28:10) Bedeutung von Messen für Radfahrende (00:29:51) Ausblick auf die Eurobike 2026 (00:32:15) Warum Messen wichtig sind (00:34:44) Klingeln bei Klötzer: Kleidung fürs kalte Nass (00:39:49) Welche Jacke? (00:45:39) Fahrt ihr mit Regenhose? (00:49:09) Überschuhe oder Winterschuhe? (00:54:00) Winterschuhe und warme Füße (00:54:37) Welche Handschuhe? (01:00:09) Retter in der Not: Tankstelle und Gemüsemarkt (01:01:34) Christians schöne Ausfahrt (01:04:52) Winterradfahren und inneres Gleichgewicht (01:07:08) Mastodon und das Fediverse (01:12:45) Lilly Allen – Pussy Palace Hier geht’s zum Gespräch mit Dirk Zedler zur Absage der Verbände: https://detektor.fm/gesellschaft/antritt-ziv-und-zukunft-fahrrad-beenden-kooperation-mit-der-eurobike Hier geht’s zum Gespräch mit Stefan Reisinger von der Eurobike 2025: https://detektor.fm/gesellschaft/antritt-stefan-reisinger-ueber-die-eurobike-2025 Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-stefan-reisinger-ueber-eurobike-kleidung-fuers-kalte-nass

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Eurobike-Chef Stefan Reisinger spricht über die Zukunft der Messe. Außerdem geht es um Bekleidung fürs Radfahren bei Nässe und Kälte. (00:00:00) Intro (00:00:44) Begrüßung und Bahngeschichten (00:07:18) Themenübersicht (00:08:06) Eurobike-Chef Stefan Reisinger im Gespräch (00:11:41) Kritikpunkte und Anforderungen an die Messe (00:17:16) mobifuture und regulatorische Herausforderungen (00:22:06) Sicht auf Cyclingworld Düsseldorf (00:28:10) Bedeutung von Messen für Radfahrende (00:29:51) Ausblick auf die Eurobike 2026 (00:32:15) Warum Messen wichtig sind (00:34:44) Klingeln bei Klötzer: Kleidung fürs kalte Nass (00:39:49) Welche Jacke? (00:45:39) Fahrt ihr mit Regenhose? (00:49:09) Überschuhe oder Winterschuhe? (00:54:00) Winterschuhe und warme Füße (00:54:37) Welche Handschuhe? (01:00:09) Retter in der Not: Tankstelle und Gemüsemarkt (01:01:34) Christians schöne Ausfahrt (01:04:52) Winterradfahren und inneres Gleichgewicht (01:07:08) Mastodon und das Fediverse (01:12:45) Lilly Allen – Pussy Palace Hier geht’s zum Gespräch mit Dirk Zedler zur Absage der Verbände: https://detektor.fm/gesellschaft/antritt-ziv-und-zukunft-fahrrad-beenden-kooperation-mit-der-eurobike Hier geht’s zum Gespräch mit Stefan Reisinger von der Eurobike 2025: https://detektor.fm/gesellschaft/antritt-stefan-reisinger-ueber-die-eurobike-2025 Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-stefan-reisinger-ueber-eurobike-kleidung-fuers-kalte-nass

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Irish Paralympian Josephine Healion joins Kathleen McNamee in studio for this week's Settle In to discuss her journey from overcoming a visual impairment diagnosis to representing Ireland in cycling events at the 2024 Paris Paralympic Games. Settle In on Off The Ball with Guinness 0.0.

Please note this episode of Type 1 on 1 contains honest discussion of severe depression at around 1'08", including suicidal thoughts. No matter how long you've been living with or close to type 1 diabetes, it remains an incredibly complex condition to understand. And while there's a wealth of information out there to dig into, knowing what to pay attention to can be just as daunting. John Pemberton is a diabetes technology consultant, children's dietician, researcher and has been living with type 1 diabetes himself for around 20 years. So if you're looking for research-backed information about the right insulin pump, want to know why 20 minutes of walking is the magic key to a stubborn high glucose reading, or you just need to start with the basics without getting overwhelmed, his diabetes education platform The Glucose Never Lies could be the answer. It was created after his young son Jude tested positive for diabetes antibodies, and when it comes to distilling complicated diabetes information and making it make sense, John is a master of the craft.In this episode we cover an incredible amount - from the professional, including his work with newly diagnosed families, the latest in diabetes research and his love of continuous glucose monitoring, to the deeply personal, including how years of undiagnosed ADHD led to severe depression and suicidal thoughts. After getting the right treatment in July 2025, John has found renewed purpose in taking The Glucose Never Lies to the next level.CONNECT WITH JOHNThe Glucose Never Lies Website The Glucose Never Lies Podcast on Spotify Diabetes Specialist Nurse Forum CGM comparison chart.DISCLAIMER Nothing you hear on Type 1 on 1 should be taken as medical advice. Please consult your healthcare team before making any changes to your diabetes or health management.JOIN THE TYPE 1 ON 1 COMMUNITY:Come and say hi @studiotype1on1 on Instagram.Visit the Type 1 on 1 website.Subscribe to the Type 1 on 1 newsletter.SPONSOR MESSAGEThis episode of Type 1 on 1 is sponsored by Dexcom. Using Dexcom CGM has given me so much confidence to make informed diabetes treatment decisions in the moment.You can choose to wear it on your arm or your abdomen, and all Dexcom CGMs have the share and follow feature even when connected to an insulin pump, so family and friends can see your glucose levels and get alerts, giving that extra bit of support when needed.Head to Dexcom.com to request a free Dexcom ONE+ sample.Always read the user manual for important product aspects and limitations. Talk to your doctor for diabetes management terms and conditions and terms of use. 

Judd, Jessi, and AJ talk about some of the major line changes ahead of the Wild's game against Carolina which will see Danila Yurov act as center on the 1st line. What to expect from this shakeup and if it'll stick. Praise for Filip Gustavsson and Jesper Wallstedt, if this 'November' version of the Wild the new normal, plus more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Judd, Jessi, and AJ talk about some of the major line changes ahead of the Wild's game against Carolina which will see Danila Yurov act as center on the 1st line. What to expect from this shakeup and if it'll stick. Praise for Filip Gustavsson and Jesper Wallstedt, if this 'November' version of the Wild the new normal, plus more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How do construction leaders make better decisions in a world overflowing with data? Recorded live at Autodesk University 2025, this conversation with Frank Phillips and Ashley Grassano from the University of Florida explores how curiosity, culture, and clear communication help teams turn raw information into meaningful action. Frank and Ashley share how the AEC industry can shift from reactive to proactive by embracing data literacy, asking better questions, and building trust between the field and the office. From forecasting risks to creating visibility across teams, this episode highlights how decision-making improves when people, process, and technology finally align. In this episode you'll learn: Why curiosity (not dashboards) is the real driver of innovation How data transparency builds trust across construction teams Practical steps for improving decision-making in fast-paced environments MEET OUR GUESTS Frank Phillips is Director of Business Affairs Technical Services at University of Florida, where he has over two decades of career experience. Ashely Grassano is Space & GIS Manager at the University of Florida. She manages a team of BIM Coordinators, Space Planners, and GIS Administrators.    TODD TAKES Make Old Buildings Smarter, Not “Smart” A campus-wide push toward digital twins is turning legacy facilities into data-ready assets. The playbook: uplift Revit to a consistent minimum spec, link key MEP assets for location and maintenance, stream live data into Tandem, and anchor everything with GIS. It's practical, phased modernization—form meets function. Data Is an Asset—Treat It Like One Ownership and flow matter. From ACC adoption to Cost rollout, success comes from redefining processes (not lift-and-shift), onboarding project-by-project, and measuring wins by outcomes (like contractors getting paid). The ethos: the owner funds the work, the owner owns the data—and partners help operationalize it. Scan, Map, Connect—and Then Automate LiDAR for utilities and interiors, geospatially aligned campus models, ACC + Tandem integration, and emerging AI/API upgrades (including easier auth) are building a true “smart campus” foundation. Pair top-down sponsorship with bottom-up field buy-in, and you get faster finds at 2 a.m., fewer “unknowns,” and clearer ROI.   MORE RESOURCES Thanks for listening! Please be sure to leave a rating and/or review and follow up our social accounts. Bridging the Gap Website Bridging the Gap LinkedIn Bridging the Gap Instagram Bridging the Gap YouTube Todd's LinkedIn   Thank you to our sponsors! Graitec North America Graitec North America LinkedIn Autodesk's Website   Other Relevant Links: Frank's LinkedIn Ashley's LinkedIn University of Florida

Tandem's Investment Team returns with Episode 22 of Tandem Talk! Tune in as the team explores the powerful passive investing feedback loop that pushes market leaders higher, a self-fulfilling prophecy in its own right—until it reverses. They discuss how extreme concentration can distort performance, the puzzle that is AI-expenditure, and what these trends may signal in an increasingly unpredictable environment.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Join Coach g on the Tandem Talk Show as he interviews Kathy Baber, a solo-living nonprofit professional who lost over 30 pounds and six pant sizes through Tandem's Metabolic Reset Program. Kathy shares how she balanced real life — frequent dining out, a busy travel schedule, and holidays — with a sustainable plan that didn't require a gym membership or extreme restriction. Topics covered include the role of accountability and coaching (Coach Lisa), practical tools Kathy used (Fitbit, food scale, walking pad, dumbbells), and how the Tandem app helped her track macros, calories, water, and particularly sodium — a key insight that reduced water retention and accelerated progress. Kathy also explains how she adapted meal plans, enjoyed favorites like protein-powered pancakes, and used the app to pre-log and balance indulgences like wine or treats around social events. The episode highlights the coaching support Kathy received (twice-weekly check-ins and restaurant-specific guidance), the non-cookie-cutter nature of the program, and the mental and emotional benefits of her transformation — from improved confidence and headshots to potential health improvements like lower cholesterol. Kathy offers advice for listeners on approaching the program with an open mind, asking questions, and using the app community for ongoing support. Expect practical tips for tracking while eating out, strategies for maintaining social life and progress through holidays, and inspiring evidence that steady, measured changes plus accountability can deliver big results without giving up the foods you love or living in a gym.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

We've got an update from Tandem Diabetes. We're talking about Libre 3 plus integration, Lyumjev approval, Mobi tubeless, extended wear infusion sets and a lot more with VP of Product Management Marisa Fienup. She's also answering your questions about tubing, alerts, and shares what's next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Information on RocketAP and other closed loop research Tandem earnings call info here  Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Emma Friedman reports.See omnystudio.com/listener for privacy information.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Cracker Barrel's attempted rebrand lit up the internet—but the logo was only the tip of the iceberg. In this episode, Robert and Kay Lee unpack what really happened: rapid, sweeping changes to brand visuals, menu staples, and in-store experience that left loyal customers feeling ignored. Robert draws on his Coca-Cola days to connect the dots to "New Coke" and other big-brand missteps. The lesson for married entrepreneurs? Expansion is great—if you bring your core with you. We talk about how to modernize without losing the soul of your brand, why you must weight research toward your existing buyers, and how "nostalgia" (surprise!) still wins with younger audiences. Translation: keep what people love, then pilot the new. You'll also hear practical ways to pressure-test change as a couple-led team—from founder interviews and customer listening to limited market tests—so you protect profits, avoid avoidable conflict at home, and buy back time you'd otherwise spend doing cleanup. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways Protect the core: modernize, don't amputate. Weight research to loyal customers before chasing new segments. Give choices (keep the classics while piloting new offers). Test small (limited locations/segments) before rolling out big. Honor the brand story—talk to founders/OG customers early. Nostalgia sells (even with Gen Z); don't discard it. Measure reality, not vibes: let sales, retention, and sentiment data lead. As spouses in business, align on "non-negotiables" first to prevent conflict later. Expand the market by adding rings around the core, not replacing it. Listen continuously—surveys, DMs, and event feedback are your free focus groups.

Pravděpodobný příští premiér Andrej Babiš (ANO) chce obnovit společná zasedání české a slovenské vlády. Ta byla v minulém roce přerušena kvůli neshodám v klíčových zahraničních tématech, především v otázce války na Ukrajině. „Je to kaňka, která bude doufám brzy napravena,“ oceňuje místopředseda hnutí ANO Radek Vodnráček Babišův záměr. „Ať vztahy obnoví, ale neuškodí tím české pozici,“ apeluje v Pro a proti Českého rozhlasu Plus europoslanec Jan Farský (STAN).

Live Life Rich Book liveliferichbook.com  Website: www.marissanehlsen.com  Instagram: @marissanehlsen Facebook: facebook.com/marissa.nehlsen  Twitter:@MarissaNehlsen LinkedIn:linkedin.com/in/marissa-Nehlsen    Eight-figure founder and wealth strategist Marissa Nehlsen returns to share how married entrepreneurs can build real wealth and protect what matters most at home. From her North Dakota roots to stewarding multiple Costa Rica retreat properties, Marissa unpacks the mindset shifts that moved her from hustle to harmony—where profit funds purpose, family, and freedom. She reveals why "keeping moving" doesn't mean doing more; it means making better, braver decisions with crystal-clear purpose. We dive into Marissa's practical frameworks: the What if / What for / What's next lens for vision, her five-question execution filter (Why, What, Who, How, When), and the habit of "giving every dollar a job." She challenges us to know our numbers, clean out calendar and business clutter, and decide what we're truly trading our lives for. You'll also hear simple rhythms she and her family practice—daily walks, weekly dinners, faith time—that keep connection strong while companies scale. Finally, Marissa breaks down her Freedom Plan—three anchors every owner needs to plot their way to time and money freedom: your Freedom Number, Freedom Date, and Freedom Sources. If you're grinding 65-hour weeks to "provide," this episode will help you re-align goals with your spouse, multiply what matters, and design a rich life emotionally, relationally, spiritually, physically, and financially. Want to experience this work in real time? Join our retreat waitlist to be first in line when we announce dates. Key Takeaways Vision before velocity: Ask What if? What for? What's next? so your growth serves your marriage, not steals from it. Five-question filter for everything: Why, What, Who, How, When—use it to build self-managing companies and a calmer home. Declutter to scale: The right things can't enter a space the wrong things occupy—edit offers, meetings, and even great-but-misaligned commitments. Know your numbers: Profit follows clarity. Track what actually moves the needle and assign every dollar a job. Build your Freedom Plan: Define your Freedom Number (what you need), Freedom Date (by when), and Freedom Sources (how it's funded). Trade-offs on purpose: Decide what you're willing to trade your life for—and confirm what your spouse actually wants (hint: it's often you, not stuff). Rituals that protect connection: Simple daily walks and weekly family meals create the margin for honest conversations and faster conflict resolution. Choose your circle wisely: You become like the five people closest to you—prioritize couples who are growing in both marriage and business. Read for ROI: Open a book's table of contents and jump to the chapter that solves today's problem—then apply it. Marissa Nehlsen Bio Marissa Nehlsen is the founder and CEO of an eight-figure, debt- free financial firm, managing over $1 billion in assets across forty- six states. Marissa's journey began on a North Dakota farm where she learned the value of hard work and resilience. For the past thirty years, she has founded five self-managing companies and coached thousands of entrepreneurs, helping them make money their best employee. Marissa is the author of the NEW book "Live Life Rich" and a dynamic keynote speaker, using her special blend of practical, tactical, and Intentional 30+ years of experience to help people move forward from where they are to where they want to be. Beyond business, Marissa is a global impact leader. She Cofounded The Foundation of Latin America, which mobilizes entrepreneurship with the purpose of eliminating poverty through the building of sewing schools for women in Costa Rica, developing sustainable energy projects, forestry, and organic farms. A mother, grandmother, and visionary leader, Marissa lives in St. Petersburg, Florida, raising her family while continuing to inspire, educate, and lead. Marissa is most excited about the launch of her healing and retreat center on her mountain in Costa Rica, set to open January 2026. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk

Welcome to the Thousand Stories podcast, the Renaissance Series.Join host Justin Brown, former Secretary of Human Services for the state of Oklahoma, and his new co-host, Luke Williams, President of Tandem Research, as they explore a true rebirth for human services.The Renaissance Series is dedicated to illuminating the stories and ideas that define this new era of innovation and transformation. We are moving toward a connected, human-centered, and innovative future in health and human services (HHS). We explore how leaders, researchers, and practitioners are building systems that truly serve people.Justin Brown originally launched the Thousand Stories podcast to share the incredible untold stories happening in Health and Human Services beyond the challenges and negative headlines. Now, the conversation centers on the belief that we are at the dawn of a renaissance in HHS, positioned at the intersection of experienced leadership and new technology innovations that can supercharge this transformation.The mission is to rethink the current system, which often operates as a "one-size-fits-all approach" that catches people at the bottom. Instead, we advocate for a custom safety net that follows us wherever we go, employing strategic interventions. This shift is essential for promoting dignity, creating better outcomes for future generations, and achieving greater efficiency for taxpayers.To achieve this, we must focus on delivery model transformation by working to remove systemic barriers (like those related to transportation, language, child care, and stigma) that prevent customers from accessing resources. A core goal is to move upstream to a more preventative posture, meeting people before they fall into crisis, preventing engagement with intrusive systems like child welfare.This series draws heavily on the research conducted by Luke Williams and Tandem Research, including their national catalog of delivery model innovations that covers 46 cases across over 38 states.In this episode, the hosts focus on the physical delivery of health and human services and the eight categories of innovation currently reshaping the field:Community Partnerships: Services delivered through formal agreements with local nonprofits, sometimes utilizing embedded workers or licensed nonprofit workers.Collocation: Partnerships between public entities, such as the one-stop shop model.Real Estate Modernization: Strategically streamlining physical office space, often coupled with distributing the workforce into the community.Mobile Service Delivery: Utilizing gutted buses or vans to provide intake and eligibility determinations in rural areas, disaster areas, or to alleviate the burden on overwhelmed physical offices.Intensive Case Management: Giving workers the tools to develop long-term career or educational pathways.Integrated Online Portals: Utilizing tools like robotic process automation (RPA) and AI for proactive intake and eligibility identification across services and agencies.Modernized Contact Centers: Using AI as a "switchboard operator" or "front man" to direct callers to specialized human teams.Tech-Driven Case Management: Using emerging technologies like AI to analyze customer data for predictive capabilities (e.g., anticipating a life event that changes service eligibility) or detecting fraud.While technology is a critical component for systems to move upstream, the hosts emphasize that the physical in-person experience is critical and will remain important for the foreseeable future, making intentional planning for the physical footprint essential. Discover how leaders are creating a meaningful and intentional mix of purpose-built physical spaces and distributed models to serve people at their most vulnerable times.

We get into the world of Tandem adventures with Di and Colin, a dynamic duo from Scotland who first rode a tandem bike on a blind date and haven't looked back since. They share about their adventures through the UK and France, and how a recent stage 4 Prostate Diagnosis has focused them more sharply on continuing to live life to the full. Follow them on the socials - FacebookRead their blog - Matilda's MusingsDonate to their fundraiserCheck out Zorali for all your outdoor adventure needs! Check out Ombraz Sunglasses - I'm a fan and I think you will be too!Support the showBuy me a coffee! I'm an affiliate for a few brands I genuinely use and recommend including:

The Alan Cox ShowSee omnystudio.com/listener for privacy information.

The Alan Cox Show

Leslie shares her teen's type 1 diabetes diagnosis and DKA, rapid self-management with Dexcom G7 and Tandem t:slim Control-IQ, ADHD challenges, camp chaos, and parenting tactics that build independence. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!